Saxagliptin monohydrate is an orally active hypoglycemic drug used mainly to manage type 2 diabetes mellitus. It belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. Saxagliptin helps control blood sugar levels by increasing levels of incretin hormones in the body, which then stimulate the pancreas to release more insulin when glucose levels are high and reduce the amount of glucose produced by the liver. This glucose-dependent mechanism lowers both fasting and postprandial blood sugar levels. It is grouped under the following drug class(es): DPP-4 inhibitors and Hypoglycemics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Saxagliptin hydrate and Saxagliptin anhydrous. Its PubChem CID is 53297473.
Saxagliptin monohydrate
| CAS No | 945667-22-1 |
|---|---|
| Molecular Formula | C18H27N3O3 |
| Molecular Weight | 333.4 g/mol |
| Synonyms | (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile;hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Saxagliptin monohydrate is an orally active hypoglycemic drug used mainly to manage type 2 diabetes mellitus. It belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors.
The listed CAS number is 945667-22-1.
The listed molecular formula is C18H27N3O3.
The listed molecular weight is 333.4 g/mol.
(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile;hydrate.
The source lists Saxagliptin hydrate and Saxagliptin anhydrous.